A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Clinical trial NCT06900920 · RECRUITING
Trial details
- NCT number
- NCT06900920
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2027-03-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.